Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer

NEW YORK ─ Belgian molecular diagnostics firm Biocartis and Portugal-based biotech firm Ophiomics on Tuesday announced that they are collaborating to commercialize a prognostic, gene-expression liver cancer test called HepatoPredict to identify patients for curative-intent surgery and liver transplantation.

Ophiomics' HepatoPredict combines clinical parameters with molecular markers to assess tumor biology, aiming to predict which patients will benefit most from a liver transplant and identifying those for which a transplant should be avoided, the firms said.

The firms said they anticipate launching HepatoPredict as a CE-marked IVD manual kit in the first quarter of 2022, mainly directed to centralized expert laboratories. Depending on its uptake, they may begin developing a version of the test on Biocartis’ Idylla platform, a fully automated sample-to-result, real-time PCR system.

Financial and other terms of the agreement were not disclosed.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.